期刊信息

  • 刊名: 河北师范大学学报(自然科学版)Journal of Hebei Normal University (Natural Science)
  • 主办: 河北师范大学
  • ISSN: 1000-5854
  • CN: 13-1061/N
  • 中国科技核心期刊
  • 中国期刊方阵入选期刊
  • 中国高校优秀科技期刊
  • 华北优秀期刊
  • 河北省优秀科技期刊

新型止吐药枸橼酸马罗匹坦的合成

  • (河北科技大学 化学与制药工程学院,河北 石家庄 050018)
  • DOI: 10.13763/j.cnki.jhebnu.nse.202203006

Synthesis of a New Antiemetic Drug Maropitant Citrate

摘要/Abstract

摘要:

以3-奎宁酮盐酸盐和苯甲醛为原料,经羟醛缩合、迈克尔加成、构型转化,制备(2S) 二苯甲基奎-3-酮(6);化合物6与苄胺形成亚胺经铂碳催化氢化还原,用L-樟脑磺酸成盐纯化,钯碳催化氢化脱除苄基,制备关键中间体(2S,3S)-2- 二苯甲基奎宁-3-胺(10).化合物10与2-甲氧基-5-叔丁基苯甲醛形成相应亚胺,经硼氢化试剂还原,得到马罗匹坦粗品,经L-樟脑磺酸成盐纯化,再与枸橼酸成盐制得枸橼酸马罗匹坦.优化了反应条件,对各步反应后处理、纯化步骤进行了改进,制备了高纯度的药用目标化合物,工艺操作简单,适合工业化生产.目标化合物结构经质谱和核磁共振氢谱确证,总收率约为20%,纯度为99.9% (HPLC).

Abstract:

Using 3-quinone hydrochloride and benzaldehyde as raw materials, (2S)-benzhydrylquinine-3-one (6) was prepared through aldol condensation, Michael addition, and configuration transformation. The imine formed from compound 6 and benzylamine was reduced by Platinum-carbon catalytic hydrogenation, and then further purified by salting with L -camphorsulfonic acid. And the key intermediate (2S,3S)2-benzhydryl-quinine3-amine (10) was prepared by Palladium-carbon catalytic hydrogenation to remove benzyl group. The crude maropiptan was synthesised by reducing the imine which was formed by compound 10 and 2-methoxy5tert-butylbenzaldehyde. The high-purity maropitant citrateIt was obtained in the mixture of acetone, water and methyl tert-butyl ether after purifing by salt formation with L-camphorsulfonic acid. The synthetic route has been optimized to make the work-up process simple and more suitable for industrial production. The chemical structure of target compound was confirmed by ESI-MS and 1HNMR, and the total yield was 20% and the purity was 99.9% (HPLC).

参考文献 11

  • [1] 岳发贵,孙薇,梁迪,等.神经激肽1受体拮抗剂研究进展[J].国际药学研究杂志,2010,37(3):203-208.doi:10.13200/j.cnki.jipr.2010.03.011 YUE Fagui,SUN Wei,LIANG Di,et al. Research Progress of Neurokinin 1 Receptor Antagonists[J]. International Journal of Pharmaceutical Research,2010,37(3):203-208.
  • [2] 于晓辉,赵富华,董玲玲,等.分子排阻色谱法测定马罗匹坦注射液中磺丁倍他环糊精钠的含量[J].安徽农业科学,2015,43(21):154-156.doi:10.13989/j.cnki.0517-6611.2015.21.057 YU Xiaohui,ZHAO Fuhua,DONG Lingling,et al. Determination of Sulbubeta-cyclodextrin Sodium in Maropitant Injection by Molecular Exclusion Chromatography[J]. Anhui Agricultural Sciences,2015,43(21):154-156.
  • [3] 许静明,陈尔阳.化疗用止吐药及其最新研究进展[J].海峡药学,2008,20(7):103-106.doi:10.3969/j.issn.1006-3765.2008.07.052 XU Jingming,CHEN Eryang. Antiemetics for Chemotherapy and Its Latest Research Progress[J]. Strait Pharmacy,2008,20(7):103-106.
  • [4] 刘婧,姜恩魁.P物质和P物质受体[J].锦州医科大学学报,2001,22(1):57-59.doi:10.3969/j.issn.1674-0424.2001.01.036 LIU Jing,JIANG Enkui. Substance P and Substance P Receptor[J]. Journal of Jinzhou Medical University,2001,22(1):57-59.
  • [5] 许萌.枸橼酸马罗匹坦注射液产品介绍 [R/OL ].法瑞瓦公司:云端兽医知识库,2017-06-12.https://www.cloudvet.org/Mapi/article/297?id=297 XU Meng. Product Introduction of Malopitant Citrate Injection [R/OL]. Fariva Company:Cloud Veterinary Knowledge Base,2017-06-12. https://www.cloudvet.org/Mapi/article/297?id=297
  • [6] 邹平,邱小龙,胡林,等.制备马罗匹坦游离碱的方法:CN201710306670.X [P/OL].2017-07-25.http://www2.drugfuture.com/cnpat/search.aspx ZOU Ping,QIU Xiaolong,HU Lin,et al. Method for Preparing Maropitant Free Base:CN201811427521. X [P/OL].2017-07-25. http://www2.drugfuture.com/cnpat/search.aspx
  • [7] 邹平,邱小龙,胡林,等.一种马罗匹坦游离碱的制备方法:CN201811427521.X [P/OL].2019-02-12.http://www2.drugfuture.com/cnpat/search.aspx ZOU Ping,QIU Xiaolong,HU Lin,et al. A Kind of Preparation Method of Maropitant Free Base:CN201811427521.X [P/OL].2019-02-12.http://www2.drugfuture.com/cnpat/search.aspx
  • [8] NUGENT THOMAS C, SEEMAYER R. Process for the Preparation of (S,S)-cis2benzhydryl-3-benzylaminoquinuclidine: WO2004035575 [P/OL].2002-10-16. https://worldwide.espacenet.com/searchResults?NUM=WO2004035575&DB=EPODOC&locale=en_EP&ST=number&compact=false
  • [9] 宋启义,黄振宇,张媛媛,等.一种含奎宁环化合物的制备方法:CN201710192594.4[P/OL].2017-03-28.http://www2.drugfuture.com/cnpat/search.aspx SONG Qiyi,HUANG Zhenyu,ZHANG Yuanyuan,et al. A Kind of Preparation Method of Compound Containing Quinuclide:CN201710192594.4 [P/OL].2017-03-28.http://www2.drugfuture.com/cnpat/search.aspx
  • [10] BASFORD P A, POST R J. Process for Preparation of (2S, 3S)2benzhydaryl-N-(5-tert-butyl2methoxybenzyl)Quinuclidin-3-amine: WO2005075473[P/OL].2004-02-02. https://worldwide.espacenet.com/searchResults?NUM=WO2005075473&DB=EPODOC&locale=en_EP&ST=number&compact=false
  • [11] TICKNER D L, MELTZ M. Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethy)-N-[2-methoxy-5-(1-methylethyl) methyl]: CN9703984 [P/OL ]. 1997-02-06. https://worldwide.espacenet.com/mydocumentslist?submitted=true&locale=en_E